Webinars
Learn from the best in healthcare. We present you with real-time developments and actionable strategies. Register to ask your immediate questions and to access our slides.
June 6, 2024 2:00 - 2:45 PM ET A Closer Look at Patient Support: Upcoming Legislative and Regulatory Changes
Avalere experts will explore how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance.
Valuing the Patient Perspective: Patient-Centered HTA
This expert panel will address the challenge of integrating patient perspectives into value assessments, discussing implications for evidence strategy, health equity, caregiver involvement, and downstream impacts on care delivery.
Decoding the CY 2025 Advance Notice
Join Avalere’s healthcare policy experts as they dissect the Advance Notice of Methodological Changes for CY 2025 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies and discuss the future trajectory of Medicare Advantage (MA) in Part D and potential outcomes, headwinds, and tailwinds for health plans.
Part D Redesign’s Impact on Plan-Manufacturer Contracting
Avalere experts discussed how IRA’s Part D redesign may affect plan behavior in Plan Year 2025 and how manufacturers should approach contracting and market access.
Demystifying IRA Drug Price Negotiation
Avalere experts will explore the potential implications of the Inflation Reduction Act (IRA)’s Medicare drug price negotiation program guidance and discuss implementation strategies for the near- and long-term.
Preparing for Legislative Change and Connecting Equity and Outcomes
Join us for a live, expert discussion on life sciences industry trends to watch in Q4.
The Evolving Cell & Gene Therapy Market
Join Avalere’s panel of market access and policy experts for a discussion on the growing cell and gene therapy (CGT) pipeline, an in-depth look at the unique opportunities and challenges these novel therapies present, and an overview of the many hurdles stakeholders need to navigate for success.
Navigating Value-Based Care, Defining Value, and Drug Pricing Policy
Join Avalere for a live discussion on key trends in drug pricing, value, and regulatory shifts, and how these trends will impact manufacturers.
CMS Final Rate Announcement: How Should Plans Prepare?
Join Avalere’s healthcare policy experts for an analysis of the final rate announcement and a discussion on the future of Medicare Advantage (MA) and potential outcomes for health plans.
Avalere 2022 Healthcare Industry Outlook: Advance Your Opportunity
From policy and regulatory changes to COVID-19 and driving customer engagement, the healthcare environment continues to require healthcare stakeholders to adapt their strategies. How will you stay ahead of the trends impacting your business?
Achieving Readiness for Radioligand Therapy in the US
Join leading clinicians and experts for a discussion of new policy recommendations for improving radioligand therapy readiness in the US.
Driving Vaccine Access and Uptake
Join us for a live conversation exploring actionable strategies for driving greater vaccine access and adoption.
Post-Pandemic Planning for Life Sciences Companies
Avalere’s data analytics and market access experts will be joined by Jeff Patton, MD and CEO of OneOncology, to explore critical issues and considerations for life sciences stakeholders following the pandemic.
Looking Ahead: The Evolving Oncology Landscape
Avalere experts examined the changing oncology landscape amid the COVID-19 pandemic.
Navigating Drug Pricing Proposals and the Role of Value
Join Avalere’s panel of data analytics, market access, and policy experts for a discussion on the potential for federal drug pricing reform in Congress or via administrative action.
Equity for Seniors: Using Data to Guide COVID-19 Pandemic Recovery
Join leading experts from Avalere Health and Tivity Health to learn more about new analyses detailing seniors’ lived experiences with the COVID-19 pandemic, including recent survey data on the vaccine rollout nationwide.
Understanding Shifting Insurance Coverage Impacts
Join Avalere’s panel of market access and policy experts to learn about the shifting insurance coverage landscape and how these trends impact manufacturers, payers, policymakers, and providers.
COVID-19: Lessons Learned and the Path Forward
Join Avalere’s panel of policy, public health, and regulatory experts to learn about the challenges, opportunities, and key milestones to watch.
Avalere 2021 Healthcare Industry Outlook: Clearing the Path
The accelerated changes and increased uncertainties in healthcare brought on by the COVID-19 pandemic will continue into 2021, and its impacts are likely to shape healthcare for years to come. While prevalent uncertainty is a given, the broad outline of a new era is already emerging. More than ever, careful examination of healthcare stakeholder’s business models, policy developments, and data will be essential to arrive at accurate assessments of the future state. Our experts engaged in a live discussion covering critical issues facing healthcare leaders and strategies for clearing the path.
For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.
2020 Election with Avalere: What’s at Stake for Healthcare Post-Election?
Avalere experts discussed how the 2020 election is influencing the future of healthcare.